Periorbital necrotising fasciitis in infants: Presentation and management of six cases

被引:5
|
作者
Khurana, Saurbhi [1 ]
Pushker, Neelam [1 ]
Naik, Sreedhara S. [1 ]
Changole, Milind Devidas [1 ]
Ghonsikar, Vishnukant [1 ]
Bajaj, Mandeep [1 ]
机构
[1] All India Inst Med Sci, Dr Rajendra Prasad Ctr Ophthalm Sci, New Delhi 110029, India
关键词
Periorbital infections in infants; necrotising fasciitis of eyelids in young children; periorbital necrosis; EYELID NECROSIS; CHILDREN;
D O I
10.1177/0049475515575671
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Purpose To present the clinical features and management of infants presenting with periorbital necrotising fasciitis (NF). Methods Retrospective case series. Results Six children were studied. The age at presentation was in the range of 5-11 months (median, 8 months). All children presented with acute onset eyelid inflammation and necrosis with fever, lethargy and poor oral intake. The management included intravenous antibiotics and repeated surgical debridement. The infection healed by 2-3 weeks in all cases, resulting in cicatricial ectropion and lagophthalmos. Full thickness skin grafting (with a Hughes tarso-conjunctival graft in one child) was performed in all patients at 3-5 weeks subsequently. Repeat surgery was required in three children. Adequate globe coverage and cosmesis was achieved in five children. Conclusion NF of eyelids is a potentially fatal infection that requires urgent and vigorous management and heals with sequelae that may need more than one surgical intervention over a period of time. Adequate cosmetic and functional outcomes can be achieved.
引用
收藏
页码:188 / 193
页数:6
相关论文
共 50 条
  • [41] Periorbital necrotizing fasciitis: clinical perspectives on nine cases
    Oliver-Gutierrez, David
    van der Veen, R. L. P.
    Ros-Sanchez, Elena
    Segura-Duch, Gloria
    Alonso, Tirso
    Herranz-Cabarcos, Alejandra
    Matas, Jessica
    Castro Seco, Roberto
    Arcediano, Miguel Angel
    Zapata, Miguel Angel
    Oliveres, Joan
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2024, 43 (10) : 2053 - 2059
  • [42] Necrotizing fasciitis of the periorbital region: from presentation to reconstructive journey
    Haque, Shameem A.
    Georgiou, Andreas
    Henderson, Hugo
    Woollard, Alexander
    EUROPEAN JOURNAL OF PLASTIC SURGERY, 2021, 44 (04) : 531 - 536
  • [43] Necrotizing fasciitis of the periorbital region: from presentation to reconstructive journey
    Shameem A. Haque
    Andreas Georgiou
    Hugo Henderson
    Alexander Woollard
    European Journal of Plastic Surgery, 2021, 44 : 531 - 536
  • [44] The clinical spectrum of necrotising fasciitis. A review of 15 cases
    Jarrett, P
    Rademaker, M
    Duffill, M
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1997, 27 (01): : 29 - 34
  • [45] Necrotising fasciitis of the extremities: implementation of new management technologies
    Corona, Pablo S.
    Erimeiku, Frank
    Mercedes Reverte-Vinaixa, Maria
    Soldado, Francisco
    Amat, Carles
    Carrera, Lluis
    INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED, 2016, 47 : S66 - S71
  • [46] Techniques for early diagnosis and management of cervicofacial necrotising fasciitis
    Lee, J. W.
    Immerman, S. B.
    Morris, L. G. T.
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2010, 124 (07): : 759 - 764
  • [47] Ascending necrotising fasciitis as a result of odontogenic infection: a report of two cases
    Shang, JM
    Breidahl, A
    Hing, NR
    Johnstone, BR
    Wiesenfeld, D
    AUSTRALIAN DENTAL JOURNAL, 2001, 46 (02) : 134 - 138
  • [48] Optimizing aesthetics following surgical management of periorbital necrotizing fasciitis
    Compton, Rebecca A.
    Konstantinou, Eleni K.
    Kapadia, Mitesh K.
    Scott, Andrew R.
    AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2020, 41 (06)
  • [49] Cervical necrotising fasciitis of odontogenic origin: A report of 11 cases - Discussion
    Tovi, F
    JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2000, 58 (12) : 1353 - 1353
  • [50] Treatment options in the management of necrotising fasciitis caused by Group A Streptococcus
    Mulla, ZD
    EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (08) : 1695 - 1700